MC - Moelis - Stock Forecast

Financial Services - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MC is currently covered by 10 analysts with an average price target of $76.45. This is a potential upside of $5.11 (7.16%) from yesterday's end of day stock price of $71.34.

Moelis's activity chart (see below) currently has 144 price targets and 135 ratings on display. The stock rating distribution of MC is 43.9% SELL, 41.46% HOLD and 14.63% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 83.1% with an average time for these price targets to be met of 418.18 days.

Highest price target for MC is $68, Lowest price target is $52, average price target is $57.83.

Most recent stock forecast was given by MANAN GOSALIA from MORGAN STANLEY on 23-Jun-2025. First documented stock forecast 12-May-2014.

Split History since 2000:

12/11/00 10 for 1

Currently out of the existing stock ratings of MC, 18 are a SELL (43.9%), 17 are a HOLD (41.46%), 6 are a BUY (14.63%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Sell

$68

$-4.08 (-5.66%)

$70

1 months 27 days ago
(23-Jun-2025)

9/10 (90%)

$8.47 (14.23%)

417

Sell

$68

$-4.08 (-5.66%)

$42

1 months 27 days ago
(23-Jun-2025)

7/14 (50%)

$8.47 (14.23%)

39

Hold

$63

$-9.08 (-12.60%)

$75

3 months 4 days ago
(15-May-2025)

6/8 (75%)

$1.93 (3.16%)

83

Hold

3 months 26 days ago
(24-Apr-2025)

5/5 (100%)

$17.36 (41.69%)

322

Hold

$52

$-20.08 (-27.86%)

$51

3 months 26 days ago
(24-Apr-2025)

6/8 (75%)

$-0.61 (-1.16%)

155

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MC (Moelis) average time for price targets to be met?

On average it took 418.18 days on average for the stock forecasts to be realized with a an average price target met ratio 83.1

Which analyst has the current highest performing score on MC (Moelis) with a proven track record?

ALEXANDER BLOSTEIN

Which analyst has the most public recommendations on MC (Moelis)?

Alexander Blostein works at GOLDMAN SACHS and has 4 price targets and 3 ratings on MC

Which analyst is the currently most bullish on MC (Moelis)?

Alexander Blostein with highest potential upside - $0

Which analyst is the currently most reserved on MC (Moelis)?

Steven Chubak with lowest potential downside - -$38.08

Moelis in the News

Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea

INSIDE INFORMATION REGULATED INFORMATION Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea U.S. Commercialization Officially Launched Mont-Saint-Guibert, Belgium – August 8, 2025, 10:10pm CET / 4:10pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive...

Nyxoah Obtient l'Autorisation de la FDA pour le Système Genio® Destiné au Traitement de l'Apnée Obstructive du Sommeil

INFORMATIONS PRIVILÉGIÉES INFORMATIONS RÉGLEMENTÉES Nyxoah Obtient l’Autorisation de la FDA pour le Système Genio® Destiné au Traitement de l’Apnée Obstructive du Sommeil Lancement Officiel de la Commercialisation aux États-Unis Mont-Saint-Guibert, Belgique – 8 juillet 2025, 22h10 CET / 16h10 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« Nyxoah » ou la « Société »), une...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?